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ApoptosisMitochondria have been shown to play a pivotal role in apoptotic signalling in various cell types. We have
recently reported that in lymphocytes the voltage-gated potassium channel Kv1.3, known to reside in the
plasma membrane, is active also in the inner mitochondrial membrane. Upon induction of apoptosis, outer-
membrane inserted Bax binds to and inhibits Kv1.3 resulting in hyperpolarization, an increase in reactive
oxygen species production and cytochrome c release. In cells lacking Kv1.3 these events do not take place.
Here, we present new data which further corroborates an important role of this channel in the sequence of
events leading to Bax-induced cytochrome c release. Recombinant Kv1.3, when pre-incubated with Bax,
prevents the actions of Bax at the level of mitochondria. Furthermore, we report the presence of Kv1.3
protein in mitochondria from PC3 and MCF-7 cancer cells, suggesting that this channel might play a role in
the apoptotic signalling not only in lymphocytes but also in other cells.l line; CTLL-2, interleukin-2
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Several plasma membrane ion channels play an essential role for
cell proliferation. A cell cycle-dependent function has been demon-
strated for some voltage-gated potassium channels (e.g. ether à go-go
[1]), Ca2+-dependent potassium channels as well as calcium and
chloride channels (for reviews see e.g. [2–5]). Along with other
membrane conductances, these channels control the membrane
voltage and Ca2+ signalling as well as intracellular ion concentration,
cytosolic pH and cell volume in proliferating cells and thus participate
in the regulation of the cell cycle, known to be altered in cancer cells.
Ion channels have an impact also on programmed cell death
(apoptosis), a process shown to be defective in many cancer types.Various plasmamembrane channels have been shown to be regulated
during apoptosis. Voltage-gated potassium channels [6–8], IP3R [9],
the ATP-gated ion channel P(2X1) [10], an outwardly rectifying
swelling-activated chloride channel [11,12] and calcium release-
induced calcium channel (ICRAC) [13] were among the ﬁrst ion chan-
nels shown to be regulated upon induction of apoptosis by various
stimuli in different cell types. In general, the plasma membrane-
located channels can be easily targeted by speciﬁc drugs, therefore ion
channels are emerging targets for anti-tumor therapy. Several
different channel inhibitors have been shown to impair tumor growth
both in vitro and in vivo (for recent review see [14]).
In addition to plasma membrane-located ion channels, several
mitochondrial ion channels, including the permeability transition
pore (PTP) and the voltage-dependent anion channel (VDAC) have
been implicated in regulation of apoptosis, especially of events taking
place at mitochondria (for review see e.g. [15–17]). Mitochondrial
potassium ﬂuxes are important for controlling the proton motive
force in energized mitochondria [18–20]. Several agents are being
developed for possible tumor therapy that act on mitochondrial
potassium channels (for review see e.g. [21]). For example, the
potassium channel openers diazoxide and cromakalim, known to
affect the mitochondrial as well as the plasma membrane KATP
channels [22], have anti-tumor potential in human neuroblastoma
and human astrocytoma [23]. Benzothiazine diazoxide have been
shown to decrease the division of leukemic cells by causing
mitochondrial membrane depolarization [24]. However certain
potassium channel openers such as minoxidil have been shown to
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blockers like amioradone and dequalinium inhibit it [25]. In a-
ccordance, glibenclamide, a KATP channel blocker acts as an anti-
tumor agent for a human gastric cell line [26]. The lack of speciﬁcity of
most drugs for mitochondrial versus plasma membrane potassium
channels as well as contradictory observations (see above) make it
difﬁcult to assign a speciﬁc role of mitochondrial potassium channels
in the regulation of tumor cell growth and/or apoptosis by using only
pharmacological strategies.
We have recently set up a genetic model in order to clarify the role
of Kv1.3 in the regulation of apoptosis in lymphocytes [27]. Kv1.3 is
the predominant type of voltage-gated Kv channel expressed in the
plasmamembrane in human lymphocytes. Its activation is a key event
in T cell proliferation [28]. In accordance, speciﬁc inhibitors of Kv1.3
have a strong immunosuppressive effect [29]. As a genetic model, we
used interleukin-2 dependent murine cytotoxic T lymphocytes (CTLL-
2), known to be deﬁcient for Kv1.3 [30] (CTLL-2/pJK), and stably
transfected these cells with Kv1.3 (CTLL-2/Kv1.3) [27]. Either absence
(in CTLL-2/pJK cells), or downregulation of Kv1.3 by siRNA in human
peripheral T lymphocytes blunted death induced by various apoptotic
stimuli [31]. Multiple evidence was obtained in favour of previously
not described mitochondrial inner membrane (IMM) localization of
the Kv1.3 (mitoKv1.3) in CTLL-2/Kv1.3 as well as in Jurkat
lymphocytes [32,33]. In T cells, mitochondria provide a powerful,
generally decisive potentiation of the apoptotic process induced by
death receptor engagement (for reviews see e.g. [34,35]). The
molecular identiﬁcation of the potassium conductance in T lympho-
cyte mitochondria (mitoKv1.3) allowed us to determine a critical role
of this channel in the regulation of apoptosis. In a previous work [31]
we provided evidence that the pro-apoptotic Bcl-2 family member
Bax interacts with and inhibits mitoKv1.3 via a lysine residue in
position 128. Events known to take place at mitochondria in various
apoptotic models, like reactive oxygen species (ROS) production,
membrane potential changes and cytochrome c release were all
dependent on the presence of mitoKv1.3.
In the present work we provide further experimental evidence in
favour of our model according to which, at least in lymphocytes, Bax
interaction with mitoKv1.3 is a crucial step, which precedes cyto-
chrome c release during apoptosis.
2. Materials and methods
Mitochondria were isolated, mitochondrial membrane potential
and cytochrome c release were determined as described previously
[31].
2.1. Confocal microscopy
Cells were washed in phosphate saline buffer (PBS), ﬁxed in PBS-
buffered 2% paraformaldehyde (pH 7.3) for 10 min, washed again and
permeabilized for 5 min with 0.1% Triton X-100. Cells were washed
again and blocked with PBS/1% FCS for 10 min, washed and stained
with FITC-labeled rabbit anti-Bax antibodies (UBI) for 45 min at room
temperature. Samples were washed 3-times in PBS and incubated for
45 min with Cy3-labeled murine anti-cytochrome c antibodies (clone
7H8.2C12, BD-Biosciences). After extensive washing, confocal mi-
croscopy was performed and analysed on a Leica confocal microscope
DMIRE 2. Sequential scanning was performed in order to exclude
cross-detection of FITC signal in the Cy3 channel and vice versa.
2.2. Reactive oxygen species (ROS) formation in intact cells
To determine the formation of reactive oxygen species cells were
stimulated as indicated or left untreated. Cells were lysed in 0.1% SDS,
0.5% deoxycholic acid, 1% Triton X-100, 10 mMEDTA, 25 mMHEPES pH
7.3, 10 mM sodium pyrophosphate, 10 mM sodium ﬂuoride, 125 mMNaCl, and 1 mg/ml cytochrome c (Sigma) as previously described in
[36,37]. Samples were immediately transferred to a cuvette, covered
with mineral oil and absorbance at 550 nm was determined.
2.3. Expression, puriﬁcation and polyacrylamide gel (PAGE) analysis of
recombinant Bax and Kv1.3
Bax (aminoacid aa 1–170) and Kv1.3 (either aa 319-523 or full
length (accession number NM_002232) or full length) were cloned
into pGEX-3X, expressed in E. coli BL21A1 and puriﬁed from bacterial
lysates using glutathione-sepharose. Bacteria were lysed in 50 ml of
25 mM HEPES, pH 7.4, 0.1% SDS, 0.5% sodium deoxycholate, 1% Triton
X-100, 125 mM NaCl, 10 mM each NaF, Na3VO4, sodium pyrophos-
phate, 10 µM each aprotinin and leupeptin (A/L), and 1 mg/ml
lysozyme. Samples were incubated on ice for 15 min, brought to
30 mM MgCl2, 5 µg/ml DNAaseI was added, and samples were
incubated for an additional 30 min. Insoluble material was clariﬁed
by a 50-min centrifugation at 11,000 g at 4 °C. The supernatant was
collected and 300 µl of glutathione Sepharose (GE Healthcare) were
added to immobilize GST-fusion proteins for 1 h at 4 °C. The beads
were pelleted by centrifugation at 500 g for 2 min, and the su-
pernatant was discarded. The pellet was washed twice with 50 ml of
the lysis buffer (minus lysozyme). After the last wash, 49.5 ml of the
supernatant was removed, the pellet was resuspended in 5 ml of
HEPES/saline (H/S) supplemented with 20 mM glutathione (pH 7.4)
and incubated for 30 min at 4 °C to detach the GST-fusion proteins.
Samples were centrifuged at 500 g for 2 min, the supernatant was
collected, diluted with 15 ml of H/S, and concentrated by a 60-min
centrifugation through size-exclusion columns (cut-off, 10,000 Da;
Viva Science, Sartorius) for Bax and Kv1.3 to 1 ml. The samples were
again diluted with 20 ml of H/S and puriﬁed via size-exclusion
columns. This procedure was performed for a total of ﬁve times to
ensure elimination of the detergents. Finally, Bax was resuspended in
H/S, Kv1.3 in H/S supplemented with micellular 0.1% NP40.
GST-Kv1.3 or GST (each 20 µg) were separated on a 5% poly-
acrylamide gel (PAGE) containing 0.1% SDS. The sample buffer
contained 41 mM Tris/HCl pH 6.8, 10% glycerol and Bromophenol
Blue, without dithiothreitol (DTT) and sodium dodecyl sulphate (SDS)
and the sample was not boiled before loading for PAGE (Fig. 4). The
gel was soaked for one hour before transblotting to polyvinylidene-
ﬂuoride (PVDF) membrane in a sampling buffer containing 9% SDS.
The blots were developedwith rabbit anti-Kv1.3 antibodies (provided
by O. Pongs) and ECL. A similar method has previously been shown to
allow detection of multimeric forms of a potassium channel from
Streptomyces lividans, according to Cortes and Perozo [38].
2.4. Binding of Margatoxin to GST-Kv1.3
We immobilized approximately 2 nmol of CHAPS-solubilized,
partly tetrameric GST-Kv1.3 on glutathione-agarose, washed the
beads, incubated with 0, 0.05, 0.1, 0.25, 0.5, 1, 2 and 4 nmol Biotin-
labeled MgTx (volume: 1 ml), washed again and incubated the
samples with 1 µg/ml alkaline phosphatase-coupled anti-Biotin
antibodies. The samples were washed again and then incubated with
AP (alkaline phosphatase) substrate (diaminobenzidine DAB tablets)
to convert the colourless substrate into a red dye. The absorption of the
samples was determined to measure binding of MgTx-Biotin to GST-
Kv1.3.
2.5. Immunoprecipitation
Fusion proteins in the soluble form were subjected to co-
immunoprecipitation experiments with a rabbit anti-mouse Kv1.3
antibody, kindly gifted by O. Pongs, directed against the external
epitope 409–525 of human Kv1.3 (cross-reactive with rat and mouse)
or a commercial rabbit anti-Kv1.3 antibody (from Alamone Lab.)
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reactive with mouse Kv1.3). Both antibodies gave the same results,
revealing co-immuno-precipitation of Kv1.3 with Bax. Western blots
were done either with the rabbit anti-Kv1.3 antibody from O. Pongs
(all data on murine cells) or antibody from Alamone, both antibodies
gave the same results.
3. Results and discussion
Recombinant Bax as well as full length Bax has previously been
shown to inhibit Kv1.3 channel activity and to physically interact with
the mitoKv1.3 protein, only in mitochondria isolated from apoptotic
cells [31]. The electrochemical gradient for K+ in energized mito-Fig. 1. ROS release and apoptosis are correlated in intact cells. (A) CTLL-2/Kv1.3 cells were
stimulated with 20 μM C6-ceramide, 1 μM staurosporine or 100 ng/ml TNFα, respectively. R
measured by FACS analysis after staining with FITC-Annexin (Roche) for 15 min at 22 °C. Giv
p>0.05 to untreated samples).chondria predicts that K+ ﬂow through an IMM-located potassium
channel should be inward. If an inﬂux of positive charge through
mitoKv1.3 is inhibited, a hyperpolarization is expected. Hyperpolar-
ization in turn results in the reduction of respiratory chain com-
ponents such as Fe/S centers, cytochromes and the ubiquinone pool,
and in enhanced production of reactive oxygen species (ROS) (e.g.:
[39,40]). In agreement, addition of recombinant Bax or of toxins,
known to inhibit Kv1.3 andmitoKv1.3 with high speciﬁcity (likeMgTx
or ShK), to isolated mitochondria in suspension resulted in hyperpo-
larization and ROS production [31]. ROS production would therefore
be expected to be associated with Kv1.3-dependent apoptosis. Fig. 1
illustrates that treatment of CTLL-2/Kv1.3 intact cells with the anti-
oxidants Tiron and N-acetylcysteine prevents the release of ROS aspre-treated for 30 min with Tiron (1 mM) or N-acetylcysteine (1 mM, NAC) and then
OS was measured as described in the Materials and methods section. (B) Apoptosis was
en are the mean±SD of 3 independent experiments each (*p <0.05, t-test to controls,
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ceramide and tumor necrosis factor (TNF) indicating that indeed
apoptosis induced by various factors is dependent on ROS in our
system.
ROS are able to oxidize thiol groups and thus to elicit mitochon-
drial depolarization by activation of the PTP [41–43]. PTP opening and
consequent Δψm decrease downstream of transient mitochondrial
hyperpolarization and/or increase in ROS production has been
reported in several studies employing drugs or Ca2+-overload to
induce apoptosis (e.g.: [44–46]). In our case, Bax-induced hyperpo-
larization was indeed followed by CSA-sensitive depolarization,
indicating that PTP opening was induced [31]. Our data are consistent
with previous studies showing a transient hyperpolarization and/or
increase of ROS followed by a MPT-mediated decrease of mitochon-
drial membrane potential upon treatment with, e.g., the cytostatic
drug BMD188, ceramide, oxygen–glucose-deprivation or staurospor-
ine to name a few [45,47–49].
ROS have also been shown to oxidize cardiolipin resulting in the
release of cytochrome c from the inner mitochondrial membrane
[50,51]. In accordance, the presence of the channel has been shown to
be crucial for both ROS release and Bax-induced cytochrome c release
as previously assayed by Western blots [31]. Fig. 2 shows confocal
microscopy studies on CTLL/pJK and CTLL/Kv1.3 that illustrate
translocation of Bax into mitochondria in both cell types upon
treatment with staurosporine but release of cytochrome c only in
Kv1.3-positive cells. These latter cell types express also mitoKv1.3 in
their mitochondria, as shown previously [31,32]. The cells were
stained with anti-cytochrome c and anti-Bax antibodies. Confocal
microscopy clearly proves that Bax migrated to mitochondria after
staurosporine treatment and was not only present in a layer directly
above or below themitochondria. The signal for cytochrome c released
in the cytoplasm is relatively weak, since confocal microscopy
visualizes thin sections. Please note that T cells are characterized by
a U-shaped nucleus, causing the observed distribution of ﬂuorescent
signal within the cell. Data of Fig. 2 togetherwith previously published
data indicate a translocation of Bax into mitochondria of CTLL-2/pJK
cells without release of cytochrome c, while the CTLL/Kv1.3 cells do
release cytochrome c into the cytoplasm upon translocation of Bax.Fig. 2. Bax migrates to mitochondria but does not induce the release of cytochrome c in Kv1
1 µM staurosporine, and stained with anti-Bax antibodies and with anti-cytochrome c antibOur data suggest that inhibition of mitoKv1.3 triggers the release
of ROS, which ﬁnally mediate release of cytochrome c. If hyperpolar-
ization, triggered by the inhibition of mitoKv1.3 by Bax, was necessary
for cytochrome c release to occur, replacing KCl by NaCl in the
suspension medium of isolated mitochondria should prevent these
events, since K+-selectivemitoKv1.3 does not carry an inward current
under these conditions. Our data conﬁrmed this hypothesis, and
showed that Bax-induced hyperpolarization and cytochrome c release
were prevented by substitution of external potassium with sodium
[31]. This result however might seem to be in contradiction with
results published by Uren et al. [52] who have shown that NaCl and
LiCl (at least 50 mM) worked as well as KCl in permitting the release
of cytochrome c upon treatment of mitochondria with t-Bid, a BH3-
only pro-apoptotic Bcl-2 family member, which activates endogenous
Bax that is attached to mitochondria. In the absence of external salt,
cytochrome c is not released because of its strong electrostatic
interactions with negative lipids in the inner mitochondrial mem-
brane. In the studies by Uren et al. [52] 10 mM potassium was how-
ever present in all experiments. In mitochondria from Jurkat cells
(Fig. 3), 10 mM KCl in the medium is sufﬁcient to allow hyperpolar-
ization of the mitochondrial membrane and ROS production upon
addition of Bax. However, cytochrome c release does not take place
with 10 mMKCl (and no other salt), while it does occur at high salt, in
agreement with the ﬁndings by Uren et al [52]. In our experiments on
KCl substitution with NaCl the salt concentration was the same
(100 mM), therefore the interaction of cytochrome c with negatively
charged phosphatidylserine is fully expected to be equally weakened
in the two cases. However, no KCl was present when the NaCl-based
medium was used. Thus, the ion substitution experiment indicates
that indeed cytochrome c release requires potassium as well as a high
ionic strength of the external medium for complete detachment.
If our model is correct, addition of recombinant Kv1.3 channel
protein which competes with endogenous mitoKv1.3 for Bax binding
should be able to prevent the effects of Bax on mitochondria. A fusion
protein consisting of a GST-tag and aa 319–523 of Kv1.3 was chosen
for these experiments. A full length GST-Kv1.3 fusion protein was also
produced, although with low expression efﬁciency. Full length Kv1.3
has previously been shown to be puriﬁed with similarly low efﬁciency.3-deﬁcient CTLL-2/pJK cells. CTLL/Kv1.3 or CTLL/pJK cells were stimulated for 1 h with
odies. Confocal microscopy images are shown.
Fig. 3. Cytochrome c release requires K+ and a high concentration of salt. The data show hyperpolarization and ROS formation after treatment of isolated mitochondria with 5 nM
GST-Bax in the presence of about 10 mM KCl (70 mM sucrose, 210 mM mannitol, 1 mM EDTA, and 10 mM HEPES/KOH, pH 7.5), while no release of cytochrome c from isolated
mitochondria was observed under these conditions. Increasing the concentration of potassium to 100 mM in the experimental medium allowed cytochrome c release. Mitochondrial
membrane potential, cytochrome c release and ROS-generation in isolated mitochondria was measured as described in Material and methods of [31].
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as detergent [53]. In our experiments, the protein was puriﬁed
from bacterial extracts with glutathione-agarose in the presence of
detergents SDS and deoxycholate. In most experiments we used GST-
Kv1.3 (aa 319–523), however, critical experiments were conﬁrmed
with a GST-fusion protein of full length Kv1.3. Native Kv1.3 is a
homotetrameric channel. To address the issue of whether tetrameric
protein is present in our preparation, we performed non-denaturing
gels (containing 0.1% SDS, according to [38]) that were blotted with
polyclonal rabbit anti-Kv1.3 antibodies. The results of 3 independent
studies show bands for monomeric, dimeric and tetrameric constructs
indicating the presence of tetrameric GST-Kv1.3 (Fig. 4A).
The tetrameric, functionally active nature of the recombinant GST-
Kv1.3 fusion protein was indicated also by the observation that it was
able to bind Margatoxin, its speciﬁc inhibitor, with high afﬁnity. To
determine MgTx binding, we immobilized soluble GST-Kv1.3 on
glutathione and tested the binding of Biotin-labeled MgTx. The data
obtained show a half maximal binding upon addition of approxi-
mately 1.1 nmol MgTx-Biotin for 2 nmol GST-Kv1.3, and near-
saturation at about 2 nmol of added MgTx-Biotin. While precision is
not sufﬁcient to determine an accurate KD, the experiments show that
the afﬁnity of GST-Kv1.3 for MgTx-Biotin is very high, in the same
range as that of membrane Kv1.3 for MgTx (110 pM, [54]). The data
also demonstrate that MgTx competes with MgTx-Biotin for bindingto immobilized GST-Kv1.3 with very similar afﬁnity, since half-
saturation of MgTx-Biotin binding is observed when equal amounts of
MgTx and MgTx-Biotin are added.
Previous studies indicated that binding of the highly speciﬁc Kv1.3
inhibitor toxins, which dock in the outer-facing vestibule of Kv1.3
(involving D386 residues), is pH dependent, and that protonation of
Histidine 404 of Kv1.3 weakens pore–toxin interaction [55]. H404 and
D386 are both present in the GST-Kv1.3 fusion protein used in our
experiments. We have previously shown that the IC50 of GST-Bax for
Kv1.3 binding increased from 4 to 12 nM when in patch clamp
experiments on T lymphocytes the bath solution pH was lowered to
pH 6.7 and to a value≫50 nM at pH 6.0. These data indicated a toxin-
like interaction of Bax with the external vestibule of Kv1.3 and
mitoKv1.3 [31]. Here we show that co-incubation of GST-Bax with
GST-Kv1.3 resulted in strong association of the two proteins (Fig. 4B)
as revealed by immunoprecipitation experiments. The strength of this
interaction signiﬁcantly decreased when pH was lowered to 6.0,
conﬁrming again that Bax binds to Kv1.3 in a manner similar to
Margatoxin. To further prove the speciﬁcity of the interaction of Bax
and Kv1.3 we added MgTx (5 μM) to GST-Kv1.3 (∼2 nM) prior to
addition of GST-Bax. As MgTx speciﬁcally binds to the pore of Kv1.3
with very high afﬁnity (IC50: 110 pM), an excess of MgTx (5 μM) will
prevent binding of Bax to Kv1.3, but only if Bax binds in the pore
region of Kv1.3. Our results show that Margatoxin indeed prevented
Fig. 4. Recombinant GST-Kv1.3 interacts with GST-Bax in vitro. (A) Monomeric, dimeric and tetrameric forms of GST-Kv1.3 are visible on non-denaturing PAGE. (B) Co-incubation of
GST-Kv1.3 with GST-Bax (∼200 ng/ml each) reveals an association of the two proteins, which is blocked by pre-incubation and neutralization of GST-Kv1.3 with Margatoxin (5 µM).
The association of the two proteins is strongly decreased by altering the pH from 7.4 to 6.0. Shown areWestern blot experiments performedwith anti-Bax and anti-Kv1.3 antibodies,
respectively, which are representative of 3 very similar results. The lower blots demonstrate that similar amounts of protein were loaded in all lanes.
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interaction of the two proteins (Fig. 4B).
Finally, we tested the effect of the recombinant GST-Kv1.3 on
membrane potential changes of isolated mitochondria induced by
toxins or Bax, as well as on Bax-induced cytochrome c release. Pre-
incubation of Margatoxin or ShK (Fig. 5A) as well as of Bax (Fig. 5B)
with recombinant GST-Kv1.3 prevented their effects on changes in
mitochondrial membrane potential. Neither early hyperpolarization,
nor later depolarization occurred, indicating that the recombinant
protein competed with endogenous mitoKv1.3 for Bax and the toxins.
The same kind of experiment was performed when assessing cyto-
chrome c release (Fig. 5C), further demonstrating that Bax interacts
with mitoKv1.3 and the importance of this interaction for cytochrome
c release.
Kv1.3, as plasma membrane channel, is known to be expressed in
different tissues and cell types, including brain, lung, thymus, spleen,
lymph node, ﬁbroblasts, B lymphocytes, T lymphocytes, tonsils,
macrophages, microglia, oligodendrocytes, osteoclasts, platelets, and
testis [56]. An altered expression level of Kv1.3 has been found in
several types of cancer [14], including prostate and breast cancer
[25,57,58]. Therefore, we checked whether Kv1.3 might be present in
the mitochondria not only of lymphocytes but also of other types of
cells. Fig. 6 shows that a mitochondrial location of Kv1.3 can beFig. 5. Pre-incubation of Bax with GST-Kv1.3 abolishes its effects on membrane potentia
Incubation of puriﬁed, Kv1.3-positive mitochondria from Jurkat with 20 nMMgTx or 10 nM
The presence of 100 nM recombinant GST-Kv1.3 during the 30-min incubation neutralized
cytometry panels show plots representative of 3 independent experiments reporting Δψm
upon application of CCCP served as control for mitochondria integrity. (C) Puriﬁed Kv1.3-exp
c, whereas pre-incubation of Bax with GST-Kv1.3 abolished the effect of Bax. Cytochrome
experiments.identiﬁed in prostate cancer PC3 and in breast cancer MCF-7 cell lines.
At equal protein quantities loaded, intensity of mitochondrial markers
Bak and prohibitin, as well as of Kv1.3 increases in puriﬁed mito-
chondria with respect to whole-cell lysate, whereas the intensity of
the plasma membrane marker Ca2+-ATP-ase PMCA and of the ER
marker Ca2+-ATP-ase SERCA decreases. These data indicate that the
presence of mitoKv1.3 in mitochondria is not restricted to lympho-
cytes. Furthermore, a functional mitoKv1.3 seems to be present also in
hippocampal mitochondria [59]. Whether mitoKv1.3 in these cells
may represent a possible target for modulating apoptosis remains to
be clariﬁed.
4. Conclusion
The data presented above further conﬁrm the importance of
mitoKv1.3 for apoptosis in lymphocytes and point to a direct in-
teraction of mitoKv1.3 with Bax. Inhibition of mitoKv1.3 by outer-
membrane inserted Bax leads to early hyperpolarization (within
5 min), ROS release, a later depolarization (15 min after treatment)
and cytochrome c release. We used low nanomolar concentrations of
Bax in our experiments. They do not exclude that Bax may also form
oligomeric pores in the membranes or that it interacts with other
mitochondrial proteins. Bax-induced cytochrome c release may welll changes in mitochondria and on cytochrome c release from isolated mitochondria.
ShK (A) or 5 nM GST-Bax (B) resulted in hyperpolarization, followed by depolarization.
the toxins and Bax and blocked their effects. Control GST was without effect. The ﬂow
in isolated Jurkat mitochondria stained with 10 nM DioC6(3). Complete depolarization
ressing mitochondria responded to incubation with GST-Bax with release of cytochrome
c release was determined by Western blotting. Blots are representative of 5 similar
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Fig. 6. Kv1.3 is located tomitochondria also in PC3 andMCF-7 cancer cells. 50 µg of total
protein per lane was loaded of whole-cell lysate (1), a membrane-enriched fraction
(2) and Percoll-puriﬁed mitochondria (3). See description in the text. Kv1.3 was
detected with an apparent MW of 64 kDa. Blots with marker proteins were obtained by
stripping and re-blotting. Differences in background are due to different exposure time
and/or development method.
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monomeric Bax representing only an early step, to be followed by
other processes, such as ROS release, detachment of cytochrome c
from the surface of the IMM, and PTP activation. Bax has recently been
shown to be inserted into the OMM ﬁrst as monomer and then
undergoing oligomerization [60]. Formation of Bax oligomers and
pore formation by Bax in the OMM may well occur independently of
the presence of Kv1.3. Although our data indicate PTP activation
downstream of Bax–Kv1.3 interaction, we should stress that they do
not discriminate whether cytochrome c efﬂux is directly linked to PTP
opening – which may induce distension of cristae and increased
availability of cytochrome c for efﬂux – or is triggered independently
of PTP — for instance, by oxidation of cardiolipin.
In summary, previous data as well as those described in the
present manuscript indicate an important function of mitoKv1.3 in
lymphocyte apoptosis. The presence of mitoKv1.3 in other cell types
as well suggests that the action of mitoKv1.3might not be restricted to
lymphocytes only.Acknowledgements
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